Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in ENSC — Ensysce Biosciences, Inc.

CIK 1533421 NEW YORK, NY
Back to ENSC Full portfolio

Position in ENSC

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,767
-$1,517 QoQ
Shares Held
6,094
0.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 17 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENSC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. ENSC ranks #434 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in ENSC

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,767 6,094
2026-03-31 $3,284 6,094
2025-12-31 $4,893 5,319
2025-09-30 $3,194 1,348
2025-06-30 $3,052 1,369
2025-03-31 $1,128 441
2024-12-31 $3,565 438
2024-09-30 $1,548 6,454
2024-06-30 $4,178 8,257
2024-03-31 $6,451 8,166
2023-12-31 $6,685 6,307
2023-09-30 $5,417 3,926
2023-06-30 $7,020 3,900
2023-03-31 $3,222 663
2022-12-31 $1 760
2022-09-30 $3,318 15,433
2022-06-30 $2,659 3,064
2022-03-31 $11,657 10,226
2021-12-31 $152,529 32,453
2021-09-30 $32,096 10,593